Parainfectious opsoclonus-myoclonus syndrome in a child on the example of a clinical case. Results of observation over 5 years
https://doi.org/10.18699/SSMJ20250322
Abstract
Opsoclonus-myoclonus syndrome is a rare symptom complex, the development of which can be induced by various factors, including infectious and oncopathology, and lead to persistent neurological deficiency, which requires timely diagnosis, treatment and long-term monitoring by specialists of various profiles. In the presented clinical case, a 2-year-old child developed a neurological syndrome in the form of a characteristic combination of opsoclonus, myoclonus, ataxia, psycho-emotional and insomnia disorders after immunization and non-specific general infectious manifestations. Stable clinical remission was achieved against the background of immunosuppressive therapy. Long-term observation for 5 years showed restoration of lost functions of the nervous system and rates of psychomotor development. The need for a comprehensive study of the long-term consequences of parainfectious opsoclonus-myoclonus syndrome is determined by the risk of developing persistent neurological deficit, developing other immunopathological conditions, relapse, and oncopathology. Diagnosis and determination of a treatment strategy for this disease in children is a complex interdisciplinary problem that requires long-term interaction and continuity of specialists of various profiles.
About the Authors
I. F. FedoseevaRussian Federation
Irina F. Fedoseeva, candidate of medical sciences
650056; Voroshilova st., 22a; Kemerovo
T. V. Poponnikova
Russian Federation
Tatiana V. Poponnikova, doctor of medical sciences, professor
650056; Voroshilova st., 22a; Kemerovo
E. N. Urban
Russian Federation
Elena N. Urban
650061; Oktyabrsky ave., 22; Kemerovo
A. V. Goncharenko
Russian Federation
Alexey V. Goncharenko, candidate of medical sciences
650056; Voroshilova st., 22a; Kemerovo
References
1. Meira A.T., de Moraes M.P.M., Ferreira M.G., Franklin G.L., Rezende Filho F.M., Teive H.A.G., Barsottini O.G.P., Pedroso J.L. Immune-mediated ataxias: Guide to clinicians. Parkinsonism Relat. Disord. 2023;117:105861. doi: 10.1016/j.parkreldis.2023.105861
2. Bhatia P., Heim J., Cornejo P., Kane L., Santiago J., Kruer M.C. Opsoclonus-myoclonus-ataxia syndrome in children. J. Neurol. 2022;269(2):750–757. doi: 10.1007/s00415-021-10536-3
3. Pranzatelli M.R., Tate E.D., McGee N.R. Multifactorial analysis of opsoclonus-myoclonus syndrome etiology (“Tumor” vs. “No tumor”) in a cohort of 356 US children. Pediatr. Blood. Cancer. 2018;65(8):e27097. doi: 10.1002/pbc.27097
4. Hsu M., Tejani I., Shah N., Olaosebikan R., Kumar A., Naik S. Review of opsoclonus-myoclonus ataxia syndrome in pediatric patients. Children (Basel). 2024;11(3):367. doi: 10.3390/children11030367
5. Monzani N.A., Corsello A., Tagliabue C., Pinzani R., Mauri E., Agostoni C., Milani G.P., Dilena R. Early acute cerebellar ataxia after meningococcal B vaccine: a case report of a 7-month-old infant and a review of the literature. Ital. J. Pediatr. 2023;49(1):61. doi: 10.1186/s13052-023-01480-1
6. Gurkas E., Gucuyener K., Yılmaz U., Havalı C., Demir E. Opsoclonus-myoclonus syndrome following rotavirus gastroenteritis. Pediatr. Int. 2014;56(6):e86–e87. doi: 10.1111/ped.12433
7. Syrbe S., Merkenschlager A., Bernhard M.K., Grosche J., Liebert U.G., Hirsch W., Härtig W. Opsoclonus-myoclonus syndrome after adenovirus infection. Springerplus. 2015;4:636. doi: 10.1186/s40064-015-1429-1
8. Shah N.S., Pathak J., Shah P.C., Bharmal U.F., Ansari M.I. A rare case of opsoclonus myoclonus ataxia syndrome post viral illness. Cureus. 2023;15(6):e40396. doi: 10.7759/cureus.40396
9. Adamaszek M., Langner S., Mehrholz J., Heiinrich A. Opsoclonus-myoclonus-ataxia syndrome due to Covid-19. Cerebellum. 2024;23(3):1245–1248. doi: 10.1007/s12311-023-01610-9
10. Yang J.C., Zekavaty S., Rossi R.D., Mahmoud S.Y. Unique magnetic resonance imaging findings in opsoclonus-myoclonus syndrome secondary to the West Nile virus. Cureus. 2024;16(8):e67932. doi: 10.7759/cureus.67932
11. Bhalodiya D., Rathore C., Gupta V., Prakash S., Pathak K. “Dancing eye, dancing feet” in cerebral malaria: A rare association. Neurol. India. 2018;66(2):543–545. doi: 10.4103/0028-3886.227326
12. Cardesa-Salzmann T.M., Mora J., García Cazorla M.A., Cruz O., Muñoz C., Campistol J. Epstein–Barr virus related opsoclonus-myoclonus-ataxia does not rule out the presence of occult neuroblastic tumors. Pediatr. Blood. Cancer. 2006;47(7):964–967. doi: 10.1002/pbc.20573
13. Cannilla H., Messe M., Girardin F., Borruat F.X., Bally J.F. Drug- and toxin-induced opsoclonus – a systematized review, including a case report on amantadine-induced opsoclonus in multiple system atrophy. Tremor Other Hyperkinet. Mov. (NY). 2024;14:23. doi: 10.5334/tohm.832
14. Desai J., Mitchell W.G. Acute cerebellar ataxia, acute cerebellitis, and opsoclonus-myoclonus syndrome. J. Child. Neurol. 2012;27(11):1482–1488. doi: 10.1177/0883073812450318
15. Fedoseeva I.F., Goncharenko A.V., Poponnikova T.V., Glebova I.V., Pinevich O.S., Goncharenko V.A. Paraneoplastic opsoclonus-myoclonus syndrome. Zhurnal nevrologii i psikhiatrii imeni Sergeya Sergeevicha Korsakova = S.S. Korsakov Journal of Neurology and Psychiatry. 2024;124(12):165–170. [In Russian]. doi: 10.17116/jnevro2024124121165
16. Fedoseeva I.F., Poponnikova T.V., Galieva G.Yu., Ilyasova O.V. Clinical observations of late infantile and juvenile forms of Niemann – Pick disease type C. Byulleten’ sibirskoy meditsiny = Bulletin of Siberian Medicine. 2017;16(3):210–217. [In Russian]. doi: 10.20538/1682-0363-2017-3-210-217
17. Rossi M., van der Veen S., Merello M., Tijssen M.A.J., van de Warrenburg B. Myoclonus-ataxia syndromes: a diagnostic approach. Mov. Disord. Clin. Pract. 2020;8(1):9–24. doi: 10.1002/mdc3.13106
18. Saini L., Dhawan S.R., Madaan P., Suthar R., Saini A.G., Sahu J.K., Sankhyan N. Infection-associated opsoclonus : a retrospective case record analysis and review of literature. J. Child. Neurol. 2020;35(7):480–484. doi: 10.1177/0883073820911327
19. Mitoma H., Manto M. Recent advances in diagnosis of immune-mediated cerebellar ataxias: novel concepts and fundamental questions on autoimmune mechanisms. J. Neurol. 2024;271(10):7046–7053. doi: 10.1007/s00415-024-12596-7
20. Rossor T., Yeh E.A., Khakoo Y., Angelini P., Hemingway C., Irani S.R., Schleiermacher G., Santosh P., Lotze T., Dale R.C., … OMS Study Group. Diagnosis and management of opsoclonus-myoclonus-ataxia syndrome in children: an international perspective. Neurol. Neuroimmunol. Neuroinflamm. 2022;9(3):e1153. doi: 10.1212/NXI.0000000000001153
21. Yıldırım M., Öncel İ., Bektaş Ö., Tanalı G., Şahin S., Kutluk T., Teber S., Anlar B. Clinical features and outcomes of opsoclonus myoclonus ataxia syndrome. Eur. J. Paediatr. Neurol. 2022;41:19–26. doi: 10.1016/j.ejpn.2022.09.002
22. Haden S.V., McShane M.A., Holt C.M. Opsoclonus myoclonus: a non-epileptic movement disorder that may present as status epilepticus. Arch. Dis. Child. 2009;94(11):897–899. doi: 10.1136/adc.2009.160044
23. Sakuma H., Shimizu Y., Saito Y., Sugai K., Inagaki M., Kaga M., Sasaki M. Electrophysiological evidence of cerebral dysfunction in childhood opsoclonus-myoclonus syndrome. Mov. Disord. 2010;25(7):940–945. doi: 10.1002/mds.23084
24. Manto M., Triarhou L.C. Ocular dysmetria, flutter, and opsoclonus: refining the oculomotor deficits in cerebellar patients. Cerebellum. 2023;22(4):506–526. doi: 10.1007/s12311-022-01444-x
25. Paliwal V.K., Chandra S., Verma R., Kalita J., Misra U.K. Clonazepam responsive opsoclonus myoclonus syndrome: additional evidence in favour of fastigial nucleus disinhibition hypothesis? J. Neural. Transm. (Vienna). 2010;117(5):613–615. doi: 10.1007/s00702-010-0366-y
26. Zouari R., Bouchaala W., Nsir S.B., Kamoun F., Triki C. Opsoclonus myoclonus induced by lamotrigine toxicity. Seizure. 2021;91:247–250. doi: 10.1016/j.seizure.2021.06.021
27. Malevich O.B., Il’ina E.S., Homyakova S.P., Kachanov D.Yu., Shamanskaya T.V., Lochmatova M.E., Varfolomeeva S.R. Opsoclonus–myoclonus syndrome in children with neurogenic tumors: a view of a neurologist. Pediatriya = Pediatria. 2019;98(2):221–226. [In Russian]. doi: 10.24110/0031-403X-2019-98-2-221-226